MedBen Rx
  • About Us
  • Genomic Testing
  • Resources
    • MedBen Rx Blog
    • Online Services, Forms & Formularies
  • Contact Us
  • MedBen Access
  • MedBen.com
Select Page

Drugmakers (Kind of) Lower Insulin Costs

Mar 21, 2023 | Brand Name Drugs, Diabetes, Generic Drugs, MedBen Rx, MedBen University, Pharmacy Benefits Manager (PBM), Prescription drugs, Rx Costs, Rx prices, Savings

Earlier this month, drug manufacturer Eli Lilly announced that it cutting the cost of two of its prescription brand insulins, Humalog and Humulin, by 70%, and capping out-of-pocket costs for privately insured patients at $35 a month. Competing...

PBMs, GoodRx on the Legislative Hot Seat

Feb 1, 2023 | Legislation, MedBen Rx, Pharmacy Benefits Manager (PBM), Rx Costs, Rx prices, Rx Spending

Pharmacy benefits managers (PBMs) are increasingly being called to answer for their questionable business practices at multiple levels of government. On the state level, in recent months: A major PBM has settled with Iowa and at least 14 other states for...

Pharmaceutical Companies Represent Nearly 2/3rds of Top Health Care Lobbyists

Dec 22, 2022 | Lobbying, Pharmacy Benefits Manager (PBM), Prescription drugs, Rx Spending

A review of the biggest spenders in health care lobbying by OpenSecrets reveals that, in the leadup to the 2021-22 election cycle, 16 of the top 25 lobbyists were pharmaceutical & health product organizations (see table below). The top health care lobbyist,...

Don’t Be an ATM for Your PBM!

Oct 18, 2022 | Formularies, MedBen Rx, Pharmacy Benefits Manager (PBM), Rx Costs, Rx Spending, Savings, White paper

Major pharmacy benefit managers (PBMs) use “smoke and mirrors” to make you believe they’re saving you money on prescription drugs: On the one hand, PBMs offer you administrative fee credits – fixed cost reductions that make up just a small...

Combat High-cost Drug Marketing with Comparative Effectiveness

Aug 8, 2022 | Comparative Effectiveness, Drug marketing, Formularies, MedBen Rx, Pharmacy Benefits Manager (PBM), Rebates

From Benefits Pro: “The median launch price of a new drug in the US soared from $2,115 in 2008 to $180,007 in 2021, a 20% annual inflation rate over the period, researchers at Harvard-affiliated Brigham and Women’s Hospital in Boston found.”Contributing to these...

Avoid the PBM Rebate Games

Jul 12, 2022 | Formularies, MedBen Rx, Pharmacy Benefits Manager (PBM), Rebates, Rx prices, Savings, White paper

MedBen Rx has prepared a whitepaper detailing the games pharmacy benefit managers (PBMs) play with administrative and rebate credits. PBMs focus on fixed cost savings to make you think you’re saving on prescription costs… but a closer look reveals that you’re...
« Older Entries
Next Entries »

Categories

  • 340B
  • Access solution
  • Access solutions
  • Acquisition Cost Index (ACI)
  • Affordable Care Act
  • Anniversaries
  • Announcements
  • Appropriateness Solutions
  • Avande
  • Average Wholesale Price
  • Benefits Advisory Conference
  • Benefits preservation
  • Biologics
  • Biosimilar
  • Brand Name Drugs
  • Brian Fargus
  • Cancer
  • Caroline Fraker
  • Case Study
  • Cholesterol
  • Chronic conditions
  • Claims
  • Client Report
  • Comparative Effectiveness
  • Compliance
  • Consolidated Appropriations Act of 2021 (CAA)
  • Cost Plus
  • Cost Plus Pricing
  • Cost projections
  • Cost Savings
  • Diabetes
  • Discounts
  • Doug Freeman
  • Drug costs
  • Drug makers
  • Drug marketing
  • Drug reimportation
  • Evidence-based research
  • Federal Trade Commission (FTC)
  • Food and Drug Administration (FDA)
  • Formularies
  • Fraud
  • Gene therapy
  • Generic Drugs
  • Genetic testing
  • Genomics
  • GLP-1s
  • Government
  • Guarantees
  • Health and Human Services
  • Health systems
  • Heart medications
  • High-value formulary
  • History
  • Humalog
  • Humira
  • Idacio
  • Inflation
  • Kurt Harden
  • Lawsuits
  • Legislation
  • Lifestyle
  • Limited Use HRA
  • Lobbying
  • Luke Burchard
  • MDMA (ecstasy)
  • MedBen
  • MedBen Access
  • MedBen Basics
  • MedBen Board of Directors\
  • MedBen employees
  • MedBen Rx
  • MedBen Rx Advocate
  • MedBen Rx Alliance
  • MedBen Rx News
  • MedBen University
  • Medicaid
  • Medicare
  • Mental health
  • Mobile app
  • Mounjaro
  • News
  • Nutrigenomics
  • Obesity
  • Online Services
  • Opinions
  • Outcomes
  • Overprescribing
  • Own Use
  • Ozempic
  • Patient advocacy program
  • Patient assistance program
  • Perigon Pharmacy 360
  • Pharmacies
  • Pharmacogenomics
  • Pharmacy Benefits Manager (PBM)
  • Pharmacy Services Administrator (PSA)
  • Precision medicine
  • Prescription drugs
  • Prescription Portal
  • Pricing solutions
  • Psychedelic drugs
  • Rebates
  • Regulatory
  • Reporting
  • Research
  • Rx Advertising
  • Rx Costs
  • Rx Facts
  • Rx prices
  • Rx Spending
  • RxDC report
  • Savings
  • Specialty Drugs
  • Spread Pricing
  • State legislation
  • Statins
  • Stelara
  • Study
  • Surveys
  • Transparency
  • Trend
  • TruDataRx
  • Trulicity
  • Value
  • Ventegra
  • Wegovy
  • Weight loss
  • Weight loss drugs
  • Weight management
  • Wellness
  • White paper
  • Zepbound
  • About Us
  • Contact Us
  • Blog
  • Online Services
  • MedBen Access
  • Sitemap
  • Privacy
  • MedBen.com

Sign Up for our Newsletter

  • This field is for validation purposes and should be left unchanged.
© 2026 MedBen Rx. All rights reserved.